Case File №
#VI-2026-0680
Golden Eagle
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | B Good | 9 | 7.8 | 5.2 | 10.0 | 3 Aug 2025 |
| Retatrutide | C Okay | 8 | 6.2 | 4.9 | 9.7 | 3 Aug 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 |
| 5-amino-1MQ | X N/A | 1 | 8.7 | 8.7 | 8.7 | 28 Mar 2025 |
| AHK-CU | X N/A | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 |
| AICAR Oral | X N/A | 1 | 6.0 | 6.0 | 6.0 | 27 Feb 2025 |
| AICAR | X N/A | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 |
| Anastrozole (Arimidex) Raw | X N/A | 1 | 8.4 | 8.4 | 8.4 | 6 May 2025 |
| Andarine S4 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 |
| Boldenone Cypionate | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Botulinum toxin | X N/A | 1 | 5.7 | 5.7 | 5.7 | 3 Jul 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 7.6 | 7.6 | 7.6 | 3 Jun 2025 |
| Epithalon | X N/A | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 |
| EPO | X N/A | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| Gonadorelin | X N/A | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| IGF-1 LR3 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 28 Mar 2025 |
| Ivermectin | X N/A | 1 | 5.3 | 5.3 | 5.3 | 28 Mar 2025 |
| KissPeptin-10 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 27 Feb 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.7 | 4.7 | 4.7 | 20 Jun 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 |
| LL37 | X N/A | 1 | 8.6 | 8.6 | 8.6 | 13 Jun 2025 |
| MOTS-C | X N/A | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.3 | 8.3 | 8.3 | 2 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 |
| NAD+ | X N/A | 1 | 8.2 | 8.2 | 8.2 | 3 Jun 2025 |
| Ovagen | X N/A | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 |
| Oxytocin Acetate | X N/A | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 |
| Pancragen | X N/A | 1 | 7.9 | 7.9 | 7.9 | 9 Jun 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 7.9 | 7.9 | 7.9 | 2 Jul 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 5.5 | 5.5 | 5.5 | 28 Mar 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 |
| Selank | X N/A | 1 | 4.0 | 2.9 | 2.9 | 2 Jul 2025 |
| Semax | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 |
| SR9009 | X N/A | 1 | 8.8 | 8.8 | 8.8 | 14 Jan 2025 |
| Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | X N/A | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 |
| Trenbolone Enanthate | X N/A | 1 | 9.1 | 9.1 | 9.1 | 6 May 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| TriTren 225 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jul 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 6.2 | 6.2 | 6.2 | 9 Jun 2025 |
| Vitamin D3 20000iu/ml | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 4.8 C | 10g | 8.9g | -11.4% | 95.72% | r2rvi6 | Lab C | Community |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.4 B | 200mg/ml | 245.6mg/ml | +22.8% | 95.82% | 0lfa00 | Lab D | Public |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.7 A | 15mg | 18.0mg | +20.0% | 95.40% | 7ujgbu | Lab C | Public |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 8.2 A | 100g | 91.4g | -8.6% | 96.69% | 43bo8f | Lab A | Community |
| 24 May 2026 | EPO | 9.6 A | 2mg | 2.5mg | +23.0% | 99.78% | 6ue9g0 | Lab E | Public |
| 24 May 2026 | Oxytocin Acetate | 5.8 B | 50mg | 45.5mg | -9.0% | 98.09% | dg2egp | Lab C | Public |
| 23 May 2026 | AHK-CU | 4.6 C | 50mg | 45.8mg | -8.4% | 97.12% | viwm24 | Lab A | Community |
| 23 May 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 4.6 C | 5mg | 6.0mg | +19.2% | 96.41% | 382zmi | Lab B | Community |
| 21 May 2026 | Tirzepatide | 5.6 C | 40mg | 46.1mg | +15.3% | 99.90% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Gonadorelin | 7.6 A | 50mg | 52.8mg | +5.6% | 99.79% | 767zug | Lab A | Community |
| 21 May 2026 | LGD-4033 (Ligandrol) | 4.6 C | 20mg | 24.8mg | +24.0% | 99.87% | xvvq2n | Lab C | Community |
| 21 May 2026 | SR9009 | 6.8 A | 20mg | 22.5mg | +12.5% | 95.15% | gu4k65 | Lab D | Public |
| 20 May 2026 | IGF-1 LR3 | 6.0 A | 5mg | 6.1mg | +21.2% | 95.62% | fgqb69 | Lab D | Public |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 8.2 A | 50mg | 61.4mg | +22.8% | 96.67% | 6fah9o | Lab G | Public |
| 17 May 2026 | 5-amino-1MQ | 9.1 A | 30mg | 31.8mg | +6.0% | 96.89% | j05c67 | Lab D | Public |
| 17 May 2026 | Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | 8.5 A | 100mg/ml | 110.2mg/ml | +10.2% | 98.58% | bk0xcj | Lab C | Public |
| 19 Jan 2026 | LL37 | 7.4 A | 50mg | 58.7mg | +17.4% | 99.84% | dw719w | Lab A | Public |
| 15 Jan 2026 | Retatrutide | 5.8 C | 5mg | 5mg | 98.80% | (no batch ID) | Lab G | Public | |
| 9 Jan 2026 | Andarine S4 | 5.4 B | 25mg | 31.2mg | +24.8% | 96.77% | c3tk8i | Lab B | Public |
| 7 Jan 2026 | Selank | 4.1 C | 20mg | 17.1mg | -14.7% | 96.44% | z0uqw2 | Lab A | Public |
| 29 Dec 2025 | Botulinum toxin | 5.8 B | 5mg | 5.2mg | +4.0% | 99.89% | jzx0b8 | Lab D | Public |
| 29 Dec 2025 | KissPeptin-10 | 6.2 A | 30mg | 27.4mg | -8.8% | 97.77% | w7q7op | Lab C | Public |
| 18 Dec 2025 | Tirzepatide | 6.9 B | 30mg | 35.6mg | +18.7% | 99.80% | Sep 15, 2025 | Lab G | Public |
| 18 Dec 2025 | Tirzepatide | 6.7 B | 60mg | 76.6mg | +27.7% | 99.80% | Sep 06, 25 | Lab G | Public |
| 18 Dec 2025 | Tirzepatide | 7.2 A | 40mg | 45.7mg | +14.3% | 99.70% | Aug 15, 25 | Lab G | Public |
| 12 Dec 2025 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 6.6 A | 100mg/ml | 103.4mg/ml | +3.4% | 96.49% | jgihit | Lab A | Public |
| 5 Dec 2025 | Boldenone Cypionate | 7.0 A | 200mg/ml | 229.9mg/ml | +15.0% | 96.59% | h7avy9 | Lab A | Community |
| 23 Nov 2025 | Retatrutide | 5.9 C | 10mg | 10.88mg | +8.8% | 99.56% | (no batch ID) | Lab A | Public |
| 17 Nov 2025 | AICAR Oral | 5.5 B | 50mg | 42.8mg | -14.5% | 98.02% | isw96h | Lab E | Public |
| 17 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 6.0 A | 30mg | 33.0mg | +9.9% | 97.80% | xjolgk | Lab D | Public |
| 17 Nov 2025 | MOTS-C | 7.4 A | 30mg | 30.4mg | +1.4% | 96.00% | suaxj3 | Lab B | Community |
| 14 Nov 2025 | AICAR | 5.2 B | 30mg | 32.1mg | +7.1% | 98.08% | pxyvfq | Lab B | Community |
| 14 Nov 2025 | Anastrozole (Arimidex) Raw | 7.3 A | 5g | 5.6g | +11.0% | 97.74% | xqndkf | Lab D | Community |
| 14 Nov 2025 | Trenbolone Enanthate | 10.0 A | 250mg/ml | 301.0mg/ml | +20.4% | 96.29% | y11g9y | Lab D | Public |
| 14 Nov 2025 | Vitamin B12 10mg/ml | 5.0 B | 100mg/ml | 102.2mg/ml | +2.2% | 98.96% | 6jvx3r | Lab F | Public |
| 4 Nov 2025 | Semax | 5.1 B | 10mg | 12.1mg | +21.2% | 95.08% | 1hipb5 | Lab D | Public |
| 23 Oct 2025 | Retatrutide | 5.0 C | 60mg | 72.4mg | +20.7% | 99.95% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | Epithalon | 4.0 C | 10mg | 9.9mg | -0.9% | 97.79% | xw8dzj | Lab B | Public |
| 17 Oct 2025 | NAD+ | 7.8 A | 30mg | 34.1mg | +13.6% | 98.21% | tshrgr | Lab E | Public |
| 17 Oct 2025 | TriTren 225 | 6.0 A | 100mg/ml | 123.8mg/ml | +23.8% | 99.36% | e6mnr6 | Lab C | Public |
| 9 Oct 2025 | Ivermectin | 4.8 C | 20mg | 17.2mg | -14.1% | 97.24% | lo0ut1 | Lab B | Public |
| 9 Oct 2025 | Ovagen | 9.0 A | 30mg | 28.1mg | -6.2% | 97.92% | 4rtnvp | Lab E | Community |
| 9 Oct 2025 | Trestolone Acetate (MENT) Raw | 7.2 A | 100g | 116.4g | +16.4% | 98.32% | v3hc40 | Lab B | Public |
| 3 Oct 2025 | Pancragen | 7.1 A | 50mg | 48.7mg | -2.7% | 98.48% | ng6a05 | Lab C | Community |
| 3 Oct 2025 | Vitamin D3 20000iu/ml | 7.5 A | 300mg/ml | 328.7mg/ml | +9.6% | 95.99% | cegw2v | Lab G | Community |
— END OF EVIDENCE LOG —